Sachem Head Capital Management LP Makes New Investment in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Sachem Head Capital Management LP bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,330,000 shares of the company's stock, valued at approximately $52,734,000. Acadia Healthcare makes up approximately 2.9% of Sachem Head Capital Management LP's holdings, making the stock its 12th biggest holding. Sachem Head Capital Management LP owned 1.43% of Acadia Healthcare at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Lindbrook Capital LLC grew its stake in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after acquiring an additional 671 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Acadia Healthcare by 69.4% during the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after purchasing an additional 345 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after acquiring an additional 301 shares in the last quarter. Signaturefd LLC lifted its stake in shares of Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after buying an additional 1,004 shares during the period. Finally, Fifth Third Bancorp lifted its stake in shares of Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after buying an additional 454 shares during the period.

Wall Street Analyst Weigh In

ACHC has been the subject of a number of recent analyst reports. Guggenheim initiated coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price objective for the company. Bank of America dropped their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Royal Bank of Canada dropped their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Barclays lowered their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday. Finally, KeyCorp lowered their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $47.94.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $26.15 on Friday. The company's 50 day simple moving average is $26.19 and its 200-day simple moving average is $35.66. The company has a market capitalization of $2.41 billion, a price-to-earnings ratio of 8.57, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. Acadia Healthcare Company, Inc. has a 1 year low of $20.36 and a 1 year high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The business had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business's revenue was up .3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.84 EPS. As a group, equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.